February 8, 2019
BONESUPPORT – Publication of pre-clinical study highlighting unique bone remodeling qualities of CERAMENT® in large bone defects
Lund, Sweden, 08.00 CET, 08 February 2019 – BONESUPPORT, anemerging leader in orthobiologics for the management of bone voids, today announces the publication of ground-breaki...
Read more
Read more
February 4, 2019
GenSight Biologics reports topline results at Week 48 of the RESCUE Phase III clinical trial of GS010 in subjects within six months of visual loss onset due to Leber Hereditary Optic Neuropathy (LHON)
Mean best-corrected visual acuity (BCVA) among GS010-treated eyes and sham-treated eyes evolved with similar trajectories, worsening to a low point, or nadir, before beginning ...
Read more
Read more
February 1, 2019
BONESUPPORTTM and Lund University to present at Orthopaedic Research Society (ORS) 2019 Annual Meeting
Lund, Sweden, 08.00 CET, 1 February 2019 – BONESUPPORTTM, anemerging leader in orthobiologics for the management of bone voids, today announces two oral presentations, and t...
Read more
Read more
January 30, 2019
Q4 incl. Full Year Report 2018
2018 was a pivotal year for Orexo
Q4 2018 highlights
Total net revenues of SEK 227.1 million (191.0), up 18.9 percent from Q4 previous year
Zubsolv® US net revenue ...
Read more
Read more
January 29, 2019
Modus Therapeutics strengthens Board with two key appointments
STOCKHOLM, SWEDEN – 29 January 2019: Modus Therapeutics AB, a company developing innovative treatments in high unmet medical need disease areas with a focus on sickle cell diseas...
Read more
Read more
January 29, 2019
Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, Austria
GAITHERSBURG, Md., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced results of its recently complet...
Read more
Read more
January 25, 2019
Nordic Nanovector – Private placement successfully completed
Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia
Oslo, Norway, 25 January 2019
Refe...
Read more
Read more
January 24, 2019
Nordic Nanovector ASA (OSE: NANO) nomination committee proposes new Chairman
Oslo, Norway, 24 January 2019
In the nomination committee's recommendation to the Company's annual general meeting in 2018, it was informed that the chairman of the bo...
Read more
Read more
January 24, 2019
Oncopeptides has completed a directed share issue of approximately SEK 546 million
January 24, 2019 - Regulatory press release
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRA...
Read more
Read more
January 17, 2019
Targovax granted European Patent for mutant-RAS neoantigen platform lead products
Extends IP protection of TG01 and TG02 until 06.05.2034
Oslo, 17 January 2019: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage company focuse...
Read more
Read more